Consultations

You are here

AVIS DE PROROGATION 2 - CONSULTATION N°17-MED-2024 - LAMIVUDINE 150MG COMP

by communication / 19 Mar, 2024

AVIS DE PROROGATION - CONSULTATION N°20-MED-2024 - SOMATROPINE INJ 4UI (1.33MG-ML)

by communication / 19 Mar, 2024

AVIS D'ATTRIBUTION PROVISOIRE - CONSULTATION N°13-MED-2024 - BACLOFENE COMP 10MG

by communication / 18 Mar, 2024

AVIS DE PROROGATION 2 CONSULTATION N°14-MED-2024 - BROMHEXINE CHL INJ 4MG-2ML

by communication / 18 Mar, 2024

AVIS DE CONSULTATION N°30-MED-2024 FLUDARABINE PHOSPHATE INJ IV 50MG

by communication / 18 Mar, 2024

AVIS DE CONSULTATION N°29-MED-2024 - DOXYCYCLINE COMP 100 MG

by communication / 18 Mar, 2024

AVIS DE PROROGATION 2 - CONSULTATION N°15-MED-2024 - PRALIDOXIME INJ 200MG

by communication / 18 Mar, 2024

AVIS DE CONSULTATION N°28-MED-2024 - PHENYLEPHRINE COLLY 10%

by communication / 18 Mar, 2024

AVIS DE PROROGATION 2 CONSULTATION N°12-MED-2024 LEVENOR-ETHINYLESTRAD COMP 015-0.03 ET 0.20-0.04MG

by communication / 17 Mar, 2024

AVIS DE PROROGATION 2 CONSULTATION N°11-MED-2024 - AMIODARONE COMP 200MG

by communication / 17 Mar, 2024

Pages

09789332719.png